Literature DB >> 464653

Lymphocyte response to mitogens in patients with malignant melanoma.

M Noack, H Bloedhorn, W P Herrmann.   

Abstract

Lymphocyte blast transformation of 23 melanoma patients was compared to that of 22 healthy persons after stimulation with the mitogens PHA, ConA, and PWM. Transformation rate of lymphocytes in microcultures was measured following 3H-Thymidin uptake in a Liquid-Scintillation-Counter. Calculations were based on analyses of variance. There was no significant difference in blastogenetic response between the 2 groups (patients and controls), but there were differences between the used mitogens.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464653     DOI: 10.1007/bf00412664

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  12 in total

1.  [Immunologic reaction-readiness in malignant melanoma].

Authors:  R Bickhardt; J Kunze
Journal:  Z Hautkr       Date:  1974-04-15

2.  Correlation of in vivo and in vitro assays of immunocompetence in cancer patients.

Authors:  S H Golub; T X O'Connell; D L Morton
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

3.  Correlation of immune reactivity and clinical status in cancer.

Authors:  P B Chretien; W J Catalona; P L Twomey; W F Sample
Journal:  Ann Clin Lab Sci       Date:  1974 Sep-Oct       Impact factor: 1.256

4.  Delayed hypersensitivity in cancer patients: cutaneous and in vitro lymphocyte response to specific antigens.

Authors:  H S Nelson
Journal:  J Natl Cancer Inst       Date:  1969-05       Impact factor: 13.506

5.  [T-lymphocytes in the peripheral blood. Study on 113 patients with malignant melanoma].

Authors:  R Klein; G R Krüger; K Sesterhenn
Journal:  Z Hautkr       Date:  1978-02-01

6.  A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.

Authors:  D J Pritchard; R E Ritts; W F Taylor; G C Miller
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

7.  Relationship between T and B lymphocyte values and prognosis in malignant melanoma.

Authors:  M G Bernengo; G Capella; M Peruccio; G Zina
Journal:  Br J Dermatol       Date:  1978-06       Impact factor: 9.302

8.  Biological aspects of human malignant melanoma.

Authors:  L Nathanson; T C Hall; S Farber
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

9.  Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage.

Authors:  W J Catalona; W F Sample; P B Chretien
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

10.  Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.

Authors:  N Thatcher; M K Palmer; N Gasiunas; D Crowther
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.